[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Novartis Ag ADR (NVS)

Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 296,087,936
  • Shares Outstanding, K 1,908,152
  • Annual Sales, $ 56,674 M
  • Annual Income, $ 13,984 M
  • EBIT $ 17,216 M
  • EBITDA $ 22,491 M
  • 60-Month Beta 0.45
  • Price/Sales 5.49
  • Price/Cash Flow 14.62
  • Price/Book 7.70

Options Overview Details

View History
  • Implied Volatility 26.80% (-0.53%)
  • Historical Volatility 28.04%
  • IV Percentile 93%
  • IV Rank 84.19%
  • IV High 28.53% on 02/03/26
  • IV Low 17.55% on 11/06/25
  • Expected Move (DTE 8) 1.66 (1.07%)
  • Put/Call Vol Ratio 0.49
  • Today's Volume 630
  • Volume Avg (30-Day) 2,049
  • Put/Call OI Ratio 2.03
  • Today's Open Interest 93,313
  • Open Int (30-Day) 86,953
  • Expected Range 152.96 to 156.28

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 21 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $2.20
  • Number of Estimates 4
  • High Estimate $2.25
  • Low Estimate $2.14
  • Prior Year $2.42
  • Growth Rate Est. (year over year) -9.09%

Price Performance

See More
Period Period Low Period High Performance
1-Month
146.60 +5.47%
on 06/22/26
160.57 -3.71%
on 07/02/26
+5.50 (+3.69%)
since 06/09/26
3-Month
142.25 +8.70%
on 04/29/26
160.57 -3.71%
on 07/02/26
-0.44 (-0.28%)
since 04/09/26
52-Week
112.34 +37.64%
on 08/01/25
170.46 -9.29%
on 02/27/26
+31.68 (+25.77%)
since 07/09/25

Most Recent Stories

More News
The Market Just Got Shaken—These 3 ETFs May Come Out Stronger

As Middle East tensions resurface and futures drop, VIG, VIGI, and FDVV offer dividend growth ETFs combining income with exposure to technology and global equities.

NVDA : 202.78 (-0.66%)
AAPL : 316.22 (+0.90%)
AVGO : 401.11 (+3.20%)
SAP : 158.46 (+0.66%)
JNJ : 259.10 (-1.63%)
RY : 208.56 (+1.36%)
NVS : 154.62 (-0.35%)
RHHBY : 52.0200 (+0.50%)
NSRGY : 103.1100 (-0.37%)
SBGSY : 61.6900 (+1.41%)
MSFT : 384.36 (+0.27%)
VIG : 238.62 (+0.51%)
VERAXA Biotech (NASDAQ: VRXA) Shareholders Should Watch Novartis Latest $1.5B ADC Acquisition

VERAXA Biotech (NASDAQ: VRXA) operates in one of biotechnology’s most active partnering environments, with pharmaceutical companies continuing to commit billions of dollars to differentiated antibody...

NVS : 154.62 (-0.35%)
GILD : 134.84 (-0.72%)
VRXA : 2.48 (-10.14%)
Haleon Just Struck a Five-Year Deal With Microsoft. Here Is What It Means for Haleon Stock.

Haleon has struck a five-year partnership with Microsoft as it looks to expand its AI transformation using Microsoft's Copilot.

TGT : 132.27 (-0.11%)
MSFT : 384.36 (+0.27%)
$SRCS : 922.36 (-1.75%)
COST : 912.97 (-4.21%)
NVS : 154.62 (-0.35%)
HLN : 9.71 (-0.41%)
GSK : 52.47 (-0.10%)
PFE : 24.25 (+0.83%)
WMT : 112.21 (-0.79%)
3 European Stocks to Carry Investors Through the Back Half of 2026

European stocks are outpacing the S&P 500 in 2026, and ArcelorMittal, Arm Holdings, and Novartis are three Euro Stoxx 50 components with index-beating returns.

MT : 62.96 (-0.40%)
FEZ : 68.14 (+0.49%)
NVS : 154.62 (-0.35%)
ARM : 327.87 (+9.20%)
SPY : 751.71 (+0.85%)
This AI Biotech Stock Landed a $10.4 Million Nvidia Investment

Nvidia’s backing highlights growing confidence in AI-powered biotech stocks.

NVDA : 202.78 (-0.66%)
GENB : 15.72 (-0.95%)
NVS : 154.62 (-0.35%)
AMGN : 363.62 (-1.19%)
As U.S. Debt Surpasses GDP, These 2 ETFs Are Emerging Winners in the “Sell America” Trade

With U.S. federal debt exceeding 100% of GDP, VXUS and IXUS offer investors international equity exposure as a hedge against rising sovereign risk.

SSNLF : 140.0000 (+114.69%)
BABA : 111.14 (+1.98%)
AZN : 178.49 (-5.70%)
VXUS : 84.90 (+0.54%)
NVS : 154.62 (-0.35%)
TME : 8.85 (+0.34%)
TSM : 436.96 (unch)
IXUS : 94.82 (+0.60%)
Amgen Expands Puerto Rico Biologics Facility With Additional $300M Investment Amid Tariff Pressure

Amgen ($AMGN) is investing an additional $300 million to expand its biologics manufacturing facility in Puerto Rico, bringing its recent commitments to the site to nearly $1 billion as drugmakers increase...

NVS : 154.62 (-0.35%)
AMGN : 363.62 (-1.19%)
Can Novartis Prove Its Pipeline Is Real Enough to Weather the Patent Cliff?

Barchart Research What to Expect from NVS Earnings NVS Generated April 27, 2026 Current Price $144.19 EPS Estimate $$2.11 Consensus Rating Moderate Buy Average Move 2.66% Can Novartis Prove Its Pipeline...

NVS : 154.62 (-0.35%)
Housing Figures, Bank Rate in Vogue Next Week

Monday U.S. Featured Earnings Verizon Communications Inc (NYSE:VZ) (Q1) EPS of $1.22, ...

GOOGL : 358.89 (-0.84%)
AAPL : 316.22 (+0.90%)
VZ : 42.24 (-0.49%)
KO : 82.63 (-0.92%)
CVX : 174.05 (-1.09%)
NVS : 154.62 (-0.35%)
MSFT : 384.36 (+0.27%)
LIN : 525.56 (-0.40%)
MA : 523.20 (+0.81%)
V : 348.20 (+0.19%)
XOM : 137.46 (-2.60%)
LLY : 1,216.95 (+0.09%)
3 Low-Volatility ETFs for Peace of Mind in Turbulent Times

With uncertainty plaguing the market, investors might be more inclined than usual to seek out low-volatility alternatives. These ETFs take multiple approaches.

SHY : 81.91 (+0.09%)
JEPI : 56.63 (+0.19%)
LVHI.BZ : N/A (N/A)
SHEL : 81.40 (-1.02%)
NVS : 154.62 (-0.35%)
IEF : 93.71 (+0.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Novartis has one of the strongest and broadest portfolio of oncology drugs and generics. It continues to build depth in 5 core therapeutic areas Cardio-Renal, Immunology, Neuroscience, Oncology and Hematology, strength in technology platforms - Targeted Protein Degradation, Cell Therapy, Gene Therapy,...

See More

Key Turning Points

3rd Resistance Point 157.14
2nd Resistance Point 156.31
1st Resistance Point 155.46
Last Price 154.62
1st Support Level 153.78
2nd Support Level 152.95
3rd Support Level 152.10

See More

52-Week High 170.46
Last Price 154.62
Fibonacci 61.8% 148.26
Fibonacci 50% 141.40
Fibonacci 38.2% 134.54
52-Week Low 112.34

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.